(NASDAQ: RMTI) Rockwell Medical's forecast annual revenue growth rate of 8.64% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 9.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 186.68%.
Rockwell Medical's revenue in 2026 is $69,258,000.On average, 4 Wall Street analysts forecast RMTI's revenue for 2026 to be $2,965,051,949, with the lowest RMTI revenue forecast at $2,799,234,438, and the highest RMTI revenue forecast at $3,105,334,824.
In 2027, RMTI is forecast to generate $3,215,157,401 in revenue, with the lowest revenue forecast at $2,939,202,071 and the highest revenue forecast at $3,470,346,137.